These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 27626705)

  • 1. Evaluation of intraoperative glove change in prevention of postoperative cerebrospinal fluid shunt infections, and the predictors of shunt infection.
    Bashir A; Sørensen P
    Br J Neurosurg; 2017 Aug; 31(4):452-458. PubMed ID: 27626705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of antibiotic-impregnated shunts on infection rate in adult hydrocephalus: a single institution's experience.
    Farber SH; Parker SL; Adogwa O; McGirt MJ; Rigamonti D
    Neurosurgery; 2011 Sep; 69(3):625-9; discussion 629. PubMed ID: 21499157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A simple method to reduce infection of ventriculoperitoneal shunts.
    Rehman AU; Rehman TU; Bashir HH; Gupta V
    J Neurosurg Pediatr; 2010 Jun; 5(6):569-72. PubMed ID: 20515328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do antibiotic-impregnated shunts in hydrocephalus therapy reduce the risk of infection? An observational study in 258 patients.
    Ritz R; Roser F; Morgalla M; Dietz K; Tatagiba M; Will BE
    BMC Infect Dis; 2007 May; 7():38. PubMed ID: 17488498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shunt infection: is there a near-miss scenario?
    Thompson DN; Hartley JC; Hayward RD
    J Neurosurg; 2007 Jan; 106(1 Suppl):15-9. PubMed ID: 17233307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shunt implantation: reducing the incidence of shunt infection.
    Choux M; Genitori L; Lang D; Lena G
    J Neurosurg; 1992 Dec; 77(6):875-80. PubMed ID: 1432129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of shunt infection incidence in high-risk subgroups receiving antibiotic-impregnated versus standard shunts.
    Parker SL; Attenello FJ; Sciubba DM; Garces-Ambrossi GL; Ahn E; Weingart J; Carson B; Jallo GI
    Childs Nerv Syst; 2009 Jan; 25(1):77-83; discussion 85. PubMed ID: 18985357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of an intraoperative double-gloving strategy on the incidence of cerebrospinal fluid shunt infection.
    Tulipan N; Cleves MA
    J Neurosurg; 2006 Jan; 104(1 Suppl):5-8. PubMed ID: 16509473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of antibiotic-impregnated shunt catheters in decreasing the incidence of shunt infection in the treatment of hydrocephalus.
    Sciubba DM; Stuart RM; McGirt MJ; Woodworth GF; Samdani A; Carson B; Jallo GI
    J Neurosurg; 2005 Aug; 103(2 Suppl):131-6. PubMed ID: 16370278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of Antibiotic Prophylaxis in Shunt Surgery.
    Li G; Pu K; Cao Y; Wang J; Sun Z; Li Q
    World Neurosurg; 2017 Dec; 108():548-554. PubMed ID: 28838878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrospinal fluid shunt infections in children over a 13-year period: anaerobic cultures and comparison of clinical signs of infection with Propionibacterium acnes and with other bacteria.
    Arnell K; Cesarini K; Lagerqvist-Widh A; Wester T; Sjölin J
    J Neurosurg Pediatr; 2008 May; 1(5):366-72. PubMed ID: 18447670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent cerebrospinal fluid shunt infection and the efficacy of reusing infected ventricular entry sites.
    Winston KR; Ho JT; Dolan SA
    J Neurosurg Pediatr; 2013 Jun; 11(6):635-42. PubMed ID: 23601015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction in CSF shunt infection over a 10-year period associated with the application of concentrated topical antibiotic powder directly to surgical wounds prior to closure.
    Beckman JM; Amankwah EK; Tetreault LL; Tuite GF
    J Neurosurg Pediatr; 2015 Dec; 16(6):648-61. PubMed ID: 26382185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrospinal fluid shunt infection: a prospective study of risk factors.
    Kulkarni AV; Drake JM; Lamberti-Pasculli M
    J Neurosurg; 2001 Feb; 94(2):195-201. PubMed ID: 11213954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost analysis of antibiotic-impregnated catheters in the treatment of hydrocephalus in adult patients.
    Farber SH; Parker SL; Adogwa O; Rigamonti D; McGirt MJ
    World Neurosurg; 2010; 74(4-5):528-31. PubMed ID: 21492607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infection of cerebrospinal fluid shunts in infants: a study of etiological factors.
    Pople IK; Bayston R; Hayward RD
    J Neurosurg; 1992 Jul; 77(1):29-36. PubMed ID: 1607969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics and treatment outcome of cerebrospinal fluid shunt-associated infections in adults: a retrospective analysis over an 11-year period.
    Conen A; Walti LN; Merlo A; Fluckiger U; Battegay M; Trampuz A
    Clin Infect Dis; 2008 Jul; 47(1):73-82. PubMed ID: 18484878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacterial contamination of surgeons gloves during shunt insertion: a pilot study.
    Sørensen P; Ejlertsen T; Aaen D; Poulsen K
    Br J Neurosurg; 2008 Oct; 22(5):675-7. PubMed ID: 19016119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CSF shunt infections in children: experiences from a population-based study.
    Enger PØ; Svendsen F; Wester K
    Acta Neurochir (Wien); 2003 Apr; 145(4):243-8; discussion 248. PubMed ID: 12748883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An analysis of cerebrospinal fluid shunt infections in adults. A clinical experience of twelve years.
    Spanu G; Karussos G; Adinolfi D; Bonfanti N
    Acta Neurochir (Wien); 1986; 80(3-4):79-82. PubMed ID: 3716894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.